4.3 Article

Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 222, Issue 1-2, Pages 29-39

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2010.02.018

Keywords

Cytokine; Dexamethasone; Systemic inflammation; Motor behaviour

Funding

  1. Pfizer Inc.
  2. Rene Baron Foundation
  3. Agencia Nacional de Promocion Cientifica y Tecnologica
  4. PIP-CONICET
  5. YPF foundation

Ask authors/readers for more resources

Neuroinflammation has been proposed as an important component of Parkinson's Disease (PD) aetiology and/or progression. However, the inflammatory components and the mechanisms underlying their effects are only partially known. By injecting an adenovirus expressing IL-1 in the striatum, we provoked progressive neurodegeneration of dopaminergic cells in the substantia nigra, motor symptoms and microglial activation. All these effects were attenuated by an anti-inflammatory treatment. Interestingly, peripheral inflammatory stimuli exacerbated IL-1 beta induced neurodegeneration and the central inflammatory reaction. These data provide evidence that central, chronic IL-1 beta expression can trigger and systemic IL-1 beta exacerbate nigral neurodegeneration and highlight the functional relevance of this cytokine in PD. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available